期刊文献+

妇科肿瘤患者血清细胞因子的表达 被引量:1

SERUM CYTOKINES EXPRESSION IN GYNECOLOGICAL TUMOR PATIENTS
下载PDF
导出
摘要 目的:探讨不同种类的妇科肿瘤患者血清IL-6、TNF-α和IFN-α的表达。方法:采用双抗体夹心ELISA法和放射免疫法。结果:不同种类的妇科恶性肿瘤患者血清IL-6、TNF-α和IFN-α水平均明显高于不同种类的妇科良性肿瘤(P<0.01,P<0.05)。4种妇科恶性肿瘤血清IL-6的表达依次为:卵巢恶性肿瘤、恶性滋养叶细胞肿瘤、子宫内膜癌、宫颈癌,其均值分别为786.89pg/ml、419.67pg/ml、186.80pg/ml、149.67pg/ml。血清TNF-α的表达依次为:宫颈癌、卵巢恶性肿瘤、恶性滋养叶细胞肿瘤、子宫内膜癌,其均值分别为850pg/ml,842.86pg/ml、725pg/ml、700pg/ml。血清IFN-α的表达依次为:宫颈癌、卵巢恶性肿瘤、子宫内膜癌、恶性滋养叶细胞肿瘤。其均值分别为:243.33pg/ml、237.89pg/ml、201.40pg/ml、198.78pg/ml。结论:3种细胞因子的测定对恶性肿瘤的病情估计和预后判断有重要价值。 Objective:To study the serum levels of interleukin 6(IL 6),tumor necrosis factor alpha(TNF α) and interferon alpha(IFN α) in gynecological tumor patients.Methods:Enzyme linked immunosorbent assay(ELISA) and radioimmunoassay were used to dertermine the levels of cytokines in serum.Results:Serum levels of IL 6,TNF α and IFN α in patients with gynecological malignant tumors were significantly higher than those in patients with gynecological benign tumors ( P<0 01,P<0 05,P<0 05 ).In gynecological malignant tumors serum IL 6 expression was ovarian malignant tumor (786 89 pg/ml),gestational trophoblastic tumor (419 67 pg/ml),carcinoma of endometrium (186 80pg/ml),carcinoma of cervix uteri(149 67 pg/ml).Serum TNF α expression was carcinoma of cervix uteri (850 pg/ml),ovarian malignant tumor (842 86 pg/ml),gestational trophoblastic tumor (725 pg/ml),carcinoma of endometrium(700 pg/ml).Serum IFN α expression was carcinoma of cervix uferi (243 33 pg/ml),ovarian malignant tumor (237 89 pg/ml),carcinoma of endometrium(201 40 pg/ml),gestational trophoblastic tumor(198 78 pg/ml).Conclusion:By using three cytokines,the patients conditions can be detected,the prognosis of gynecological malignant tumors can be estimated.
出处 《滨州医学院学报》 1998年第6期543-545,共3页 Journal of Binzhou Medical University
关键词 妇科肿瘤 IL-6 干扰素 肿瘤坏死因子 gynecological tumor interleukin 6 interferon alpha tumor necrosis factor alpha
  • 相关文献

参考文献1

二级参考文献3

  • 1Hsu M M,Arch Otolaryngol Head Neck Surg,1991年,117卷,1257页
  • 2姚--,病毒学杂志,1990年,4卷,347页
  • 3杨贵贞,免疫生物工程纲要与技术,1990年

共引文献10

同被引文献5

  • 1Weidner N. New paradigm for vessel in travasation by tumor cells. Am J Patho1,2002,60 : 1937-1939.
  • 2Fangha PK, Li XF, Shams M, et al. fibroblast growth factor receptor-1 is a critical component for endometrial remodeling:Localization and express- ing of flbroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia, Lab Tnvest, 1997,77:389.
  • 3Pepper MS, Mandriota SJ. Regulation of vascular endothelial growth factor receptor-2 ( Flk-1 ) expression in vascular in endothelar cells. Exp-Cell-Res, 1998,241:414.
  • 4Gelin J, Moldawer LL, Lonnroth C, et al. Role of endogenous tumor necro- sis factoral alpha and interleukin-1 for experimental tumor growth and the development of cancer cachexia. Cancer Res, 1991,51:415.
  • 5孙宝治,蔡斐茜.子宫的内分泌功能及作用[J].中国实用妇科与产科杂志,1999,15(5):277-279. 被引量:138

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部